215 related articles for article (PubMed ID: 23694797)
1. Cholangiocarcinoma: risk factors, environmental influences and oncogenesis.
Al-Bahrani R; Abuetabh Y; Zeitouni N; Sergi C
Ann Clin Lab Sci; 2013; 43(2):195-210. PubMed ID: 23694797
[TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of cholangiocarcinoma carcinogenesis.
Maemura K; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):754-60. PubMed ID: 24895231
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.
Xu AM; Xian ZH; Zhang SH; Chen XF
Eur J Gastroenterol Hepatol; 2009 May; 21(5):580-4. PubMed ID: 19282767
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of biliary carcinogenesis and growth.
Wise C; Pilanthananond M; Perry BF; Alpini G; McNeal M; Glaser SS
World J Gastroenterol; 2008 May; 14(19):2986-9. PubMed ID: 18494047
[TBL] [Abstract][Full Text] [Related]
8. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
Parkin DM; Ohshima H; Srivatanakul P; Vatanasapt V
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):537-44. PubMed ID: 8268770
[TBL] [Abstract][Full Text] [Related]
10. Transplantation for cholangiocarcinoma.
Masuoka HC; Rosen CB
Clin Liver Dis; 2011 Nov; 15(4):699-715. PubMed ID: 22032524
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma: risk factors and clinical presentation.
Gatto M; Alvaro D
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):363-7. PubMed ID: 20496549
[TBL] [Abstract][Full Text] [Related]
13. Preneoplastic conditions underlying bile duct cancer.
Sibulesky L; Nguyen J; Patel T
Langenbecks Arch Surg; 2012 Aug; 397(6):861-7. PubMed ID: 22391777
[TBL] [Abstract][Full Text] [Related]
14. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells.
Yokomuro S; Tsuji H; Lunz JG; Sakamoto T; Ezure T; Murase N; Demetris AJ
Hepatology; 2000 Jul; 32(1):26-35. PubMed ID: 10869285
[TBL] [Abstract][Full Text] [Related]
15. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
[TBL] [Abstract][Full Text] [Related]
17. Pesticides, fresh water fish, liver flukes and nitrosamines: A story of cholangiocarcinoma development in Thailand.
Wiwanitkit V
Asian Pac J Cancer Prev; 2009; 10(5):961-2. PubMed ID: 20162855
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
19. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.
Komori J; Marusawa H; Machimoto T; Endo Y; Kinoshita K; Kou T; Haga H; Ikai I; Uemoto S; Chiba T
Hepatology; 2008 Mar; 47(3):888-96. PubMed ID: 18306229
[TBL] [Abstract][Full Text] [Related]
20. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
Torbenson M; Yeh MM; Abraham SC
Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
